Detalhe da pesquisa
1.
A pilot study evaluating the safety and CD34+ cell mobilizing activity of escalating doses of plerixafor in healthy volunteers.
Br J Haematol
; 153(1): 66-75, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21352197
2.
Repeated PR1 and WT1 peptide vaccination in Montanide-adjuvant fails to induce sustained high-avidity, epitope-specific CD8+ T cells in myeloid malignancies.
Haematologica
; 96(3): 432-40, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21134985
3.
Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study.
Haematologica
; 94(3): 348-54, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19181786
4.
Lenalidomide-induced upregulation of CD80 on tumor cells correlates with T-cell activation, the rapid onset of a cytokine release syndrome and leukemic cell clearance in chronic lymphocytic leukemia.
Haematologica
; 94(9): 1266-73, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19734418
5.
Anti-interleukin-2 receptor antibody (daclizumab) treatment of corticosteroid-refractory autoimmune thrombocytopenic purpura.
Haematologica
; 91(2): 277-8, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16461323
6.
Clinical and immunologic assessment of patients with psoriasis in a randomized, double-blind, placebo-controlled trial using recombinant human interleukin 10.
Arch Dermatol
; 138(10): 1341-6, 2002 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-12374540
7.
Alemtuzumab treatment of intermediate-1 myelodysplasia patients is associated with sustained improvement in blood counts and cytogenetic remissions.
J Clin Oncol
; 28(35): 5166-73, 2010 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-21041705
8.
Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies.
Blood
; 111(1): 236-42, 2008 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17875804
9.
Improved outcome for peripheral blood stem cell transplantation for advanced primary myelodysplastic syndrome.
Biol Blood Marrow Transplant
; 11(8): 619-26, 2005 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16041312
10.
Recombinant humanized anti-IL-2 receptor antibody (daclizumab) produces responses in patients with moderate aplastic anemia.
Blood
; 102(10): 3584-6, 2003 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12881307